Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Oxeltis and Molecular Forecaster Inc. (MFI), a computational chemistry company, announced a strategic partnership, leveraging the strengths of both organizations to offer the seamless integration of in silico design with high-quality chemical ...
read more
Veeva Systems and Sarah Cannon Research Institute (SCRI) announced a strategic collaboration to drive speed and efficiency in oncology clinical trials across SCRI's more than 200 research site locations.
read more
Simtra BioPharma Solutions has formed a five-year strategic alliance with the Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada. The partnership brings together the strengths of two ...
read more
Ascend Advanced Therapies, a gene-to-GMP development service provider, has received GMP certification for Quality Control (QC) testing at its site in Munich, Germany.
read more
WuXi Biologics has kicked off construction of its new microbial manufacturing site for commercial production in the Wenjiang district of Chengdu, a hub for pharmaceutical development.
read more
Alida Biosciences announced its first official service provider: the Genomic and RNA Profiling (GARP) Core at Baylor College of Medicine. This new service offering is powered by AlidaBio's EpiPlex™ Platform, the first and only solution that ...
read more
Sanyou Biopharmaceuticals announced the signing of a strategic cooperation agreement with Medicovestor a biotechnology company pioneering first-in-class chemoimmunotherapy antibody-drug conjugates (ADCs).
read more
Axio BioPharma and Likarda announced a strategic partnership to accelerate innovation in biologic drug development. This collaboration will integrate Likarda's proprietary delivery technologies with Axio's manufacturing capabilities, creating a more ...
read more
Lipella Pharmaceuticals has re-signed its manufacturing collaboration agreement with Cook MyoSite to support Chemistry, Manufacturing and Control (CMC) documentation supporting their clinical products LP-10 and LP-310.
read more
Frontage Laboratories unveiled its newest Contract Research, Development and Manufacturing Organization (CRDMO) facility during a grand open house event held on May 22, 2025, at its campus in Exton, Pennsylvania.
read more
Zydus Lifesciences announced its entry into the global biologics contract development and manufacturing organization (CDMO) business through its plan to acquire Agenus Inc.'s U.S.-based biologics CMC facilities. This acquisition marks Zydus' ...
read more
CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced a strategic co-investment of more than CHF 25 million with a long-standing Japanese customer to expand ...
read more
Made Scientific announced a significant expansion of its Princeton, New Jersey facility to meet increasing demand from late-phase and commercial clients and support the anticipated rise in approved advanced therapies.
read more
Bora Pharmaceuticals announced that due to continued growth in demand for its drug product services, it plans to add further sterile fill/finish capacity at its facility in Baltimore, Maryland.
read more
PharmaLogic Holdings Corp. announced the company has appointed Etienne Montagut, currently serving as President, to the position of President and Chief Executive Officer, effective as of 1 June 2025.
read more